BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24498991)

  • 21. Anti-tumor activity of an immunotoxin (TGFα-PE38) delivered by attenuated Salmonella typhimurium.
    Lim D; Kim KS; Kim H; Ko KC; Song JJ; Choi JH; Shin M; Min JJ; Jeong JH; Choy HE
    Oncotarget; 2017 Jun; 8(23):37550-37560. PubMed ID: 28473665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo cytotoxic activities of recombinant immunotoxin 8H9(Fv)-PE38 against breast cancer, osteosarcoma, and neuroblastoma.
    Onda M; Wang QC; Guo HF; Cheung NK; Pastan I
    Cancer Res; 2004 Feb; 64(4):1419-24. PubMed ID: 14973056
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Schniering J; Benešová M; Brunner M; Haller S; Cohrs S; Frauenfelder T; Vrugt B; Feghali-Bostwick C; Schibli R; Distler O; Müller C; Maurer B
    Front Immunol; 2019; 10():2724. PubMed ID: 31824505
    [No Abstract]   [Full Text] [Related]  

  • 24. Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma.
    Kreitman RJ; Bailon P; Chaudhary VK; FitzGerald DJ; Pastan I
    Blood; 1994 Jan; 83(2):426-34. PubMed ID: 8286741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation of a recombinant immunotoxin in a tumor in vivo: fewer than 1000 molecules per cell are sufficient for complete responses.
    Kreitman RJ; Pastan I
    Cancer Res; 1998 Mar; 58(5):968-75. PubMed ID: 9500458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The folate receptor β as a macrophage-mediated imaging and therapeutic target in rheumatoid arthritis.
    Chandrupatla DMSH; Molthoff CFM; Lammertsma AA; van der Laken CJ; Jansen G
    Drug Deliv Transl Res; 2019 Feb; 9(1):366-378. PubMed ID: 30280318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Treatment for Glomerular Disease: Targeting the Activated Macrophage Folate Receptor with a Trojan Horse Therapy in Rats.
    Garcia GE; Lu YJ; Truong LD; Roncal-Jiménez CA; Miyazaki M; Miyazaki-Anzai S; Cara-Fuentes G; Andres-Hernando A; Lanaspa M; Johnson RJ; Leamon CP
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-chain immunotoxin fusions between anti-Tac and Pseudomonas exotoxin: relative importance of the two toxin disulfide bonds.
    Kreitman RJ; Batra JK; Seetharam S; Chaudhary VK; FitzGerald DJ; Pastan I
    Bioconjug Chem; 1993; 4(2):112-20. PubMed ID: 7873642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of relative binding affinity on efficacy in a panel of anti-CD3 scFv immunotoxins.
    Hexham JM; Dudas D; Hugo R; Thompson J; King V; Dowling C; Neville DM; Digan ME; Lake P
    Mol Immunol; 2001 Sep; 38(5):397-408. PubMed ID: 11684296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete regression of human B-cell lymphoma xenografts in mice treated with recombinant anti-CD22 immunotoxin RFB4(dsFv)-PE38 at doses tolerated by cynomolgus monkeys.
    Kreitman RJ; Wang QC; FitzGerald DJ; Pastan I
    Int J Cancer; 1999 Mar; 81(1):148-55. PubMed ID: 10077166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic efficacy of Cintredekin Besudotox (IL13-PE38QQR) in murine lung fibrosis is unaffected by immunity to Pseudomonas aeruginosa exotoxin A.
    Rosada RS; Moreira AP; Frantz FG; Puri RK; Rahman A; Standiford TJ; Zárate-Bladés CR; Silva CL; Hogaboam CM
    PLoS One; 2010 Jan; 5(1):e8721. PubMed ID: 20090941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Construction, expression and functional characterization of disulfide-stabilized anti-hepatocarcinoma single chain Fv fused with truncated Pseudomonas exotoxin].
    Zhao J; Sun ZW; Liu YF; Yu WY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Nov; 19(6):585-7. PubMed ID: 15182657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential.
    Yu Y; Li J; Zhu X; Tang X; Bao Y; Sun X; Huang Y; Tian F; Liu X; Yang L
    Int J Nanomedicine; 2017; 12():1969-1983. PubMed ID: 28331319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies of the expression, purification, renaturation and biologic activity of an anti-CEA immunotoxin].
    Yang H; He D; Chao K; Lin Q; You S; Huang HL
    Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):348-51. PubMed ID: 15971603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning, expression and characterization of the Fv fragments of the anti-carbohydrate mAbs B1 and B5 as single-chain immunotoxins.
    Benhar I; Pastan I
    Protein Eng; 1994 Dec; 7(12):1509-15. PubMed ID: 7716163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude mice.
    Reiter Y; Wright AF; Tonge DW; Pastan I
    Int J Cancer; 1996 Jul; 67(1):113-23. PubMed ID: 8690511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity.
    Weldon JE; Xiang L; Chertov O; Margulies I; Kreitman RJ; FitzGerald DJ; Pastan I
    Blood; 2009 Apr; 113(16):3792-800. PubMed ID: 18988862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxicity of antiosteosarcoma recombinant immunotoxins composed of TP-3 Fv fragments and a truncated Pseudomonas exotoxin A.
    Onda M; Olafsen T; Tsutsumi Y; Bruland OS; Pastan I
    J Immunother; 2001; 24(2):144-50. PubMed ID: 11265772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of epitopes on a mutant form of Pseudomonas exotoxin using serum from humans treated with Pseudomonas exotoxin containing immunotoxins.
    Roscoe DM; Pai LH; Pastan I
    Eur J Immunol; 1997 Jun; 27(6):1459-68. PubMed ID: 9209499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of a single-chain immunotoxin that selectively kills lymphoma and other B-lineage cells expressing the CD40 antigen.
    Francisco JA; Gilliland LK; Stebbins MR; Norris NA; Ledbetter JA; Siegall CB
    Cancer Res; 1995 Jul; 55(14):3099-104. PubMed ID: 7541711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.